IDX — Integral Diagnostics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapSuper Stock

Annual balance sheet for Integral Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2022 June 30th	R2023 June 30th	2024 June 30th	R2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	123	33.9	42.4	52.1	51.3
Net Total Accounts Receivable
Net Total Receivables	24.3	23.9	27.2	32.2	35.7
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	154	62.7	74.8	95.3	99.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	231	282	270	468	477
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	783	824	744	1,425	1,427
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	80	82.7	85.7	142	149
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	436	451	443	734	748
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	347	373	302	691	680
Total Liabilities & Shareholders' Equity	783	824	744	1,425	1,427
Total Common Shares Outstanding